Related references
Note: Only part of the references are listed.Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Elayne Hondares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
FGF21 as an Endocrine Regulator in LipidMetabolism: From Molecular Evolution to Physiology and Pathophysiology
Yusuke Murata et al.
JOURNAL OF NUTRITION AND METABOLISM (2011)
Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
Knut Mai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Biological effects of growth hormone on carbohydrate and lipid metabolism
Archana Vijayakumar et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
Andrew C. Adams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor α
Yongjun Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transcriptional Repressor E4-binding Protein 4 (E4BP4) Regulates Metabolic Hormone Fibroblast Growth Factor 21 (FGF21) during Circadian Cycles and Feeding
Xin Tong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fibroblast Growth Factor-21 May Mediate Growth Hormone Resistance in Anorexia Nervosa
Pouneh K. Fazeli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects
Jing Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Growth hormone and protein metabolism
Niels Moller et al.
CLINICAL NUTRITION (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21
Knut Mai et al.
DIABETES (2009)
Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
Yuhei Hotta et al.
ENDOCRINOLOGY (2009)
FGF21 N- and C-termini play different roles in receptor interaction and activation
Junming Yie et al.
FEBS LETTERS (2009)
β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W. Walters et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Daniel Cuevas-Ramos et al.
CURRENT DIABETES REVIEWS (2009)
Inhibition of growth hormone signaling by the fasting-induced hormone FGF21
Takeshi Inagaki et al.
CELL METABOLISM (2008)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Cecilia Gaelman et al.
CELL METABOLISM (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
Circadian expression of FGF21 is induced by PPARα activation in the mouse liver
Katsutaka Oishi et al.
FEBS LETTERS (2008)
FGF21 attenuates lipolysis in human adipocytes -: A possible link to improved insulin sensitivity
Peter Arner et al.
FEBS LETTERS (2008)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1
Derek LeRoith et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone
H Norrelund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults
M Segerlantz et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults
M Segerlantz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
S Nielsen et al.
DIABETES (2001)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
T Nishimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
The role of STAT proteins in growth hormone signaling
J Herrington et al.
ONCOGENE (2000)